WO1993000077A1
(en)
*
|
1991-06-21 |
1993-01-07 |
University Of Cincinnati |
Orally administrable therapeutic proteins and method of making
|
US6613332B1
(en)
|
1991-06-21 |
2003-09-02 |
The University Of Cincinnati |
Oral administration of therapeutic proteins
|
US5266331A
(en)
†
|
1991-11-27 |
1993-11-30 |
Euroceltique, S.A. |
Controlled release oxycodone compositions
|
US5478577A
(en)
*
|
1993-11-23 |
1995-12-26 |
Euroceltique, S.A. |
Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US5472712A
(en)
*
|
1991-12-24 |
1995-12-05 |
Euroceltique, S.A. |
Controlled-release formulations coated with aqueous dispersions of ethylcellulose
|
US5681585A
(en)
|
1991-12-24 |
1997-10-28 |
Euro-Celtique, S.A. |
Stabilized controlled release substrate having a coating derived from an aqueous dispersion of hydrophobic polymer
|
US5958459A
(en)
*
|
1991-12-24 |
1999-09-28 |
Purdue Pharma L.P. |
Opioid formulations having extended controlled released
|
US5968551A
(en)
*
|
1991-12-24 |
1999-10-19 |
Purdue Pharma L.P. |
Orally administrable opioid formulations having extended duration of effect
|
US7070806B2
(en)
*
|
1992-01-27 |
2006-07-04 |
Purdue Pharma Lp |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
US20080075781A1
(en)
*
|
1992-11-25 |
2008-03-27 |
Purdue Pharma Lp |
Controlled release oxycodone compositions
|
DE4310012A1
(de)
*
|
1993-03-27 |
1994-09-29 |
Roehm Gmbh |
Dermales therapeutisches System aus einer schmelzfähigen Poly(meth)acrylat-Mischung
|
IL119660A
(en)
*
|
1993-05-10 |
2002-09-12 |
Euro Celtique Sa |
Controlled release formulation comprising tramadol
|
US20070275062A1
(en)
*
|
1993-06-18 |
2007-11-29 |
Benjamin Oshlack |
Controlled release oxycodone compositions
|
IL110014A
(en)
*
|
1993-07-01 |
1999-11-30 |
Euro Celtique Sa |
Solid controlled-release oral dosage forms of opioid analgesics
|
US7740881B1
(en)
*
|
1993-07-01 |
2010-06-22 |
Purdue Pharma Lp |
Method of treating humans with opioid formulations having extended controlled release
|
US5879705A
(en)
*
|
1993-07-27 |
1999-03-09 |
Euro-Celtique S.A. |
Sustained release compositions of morphine and a method of preparing pharmaceutical compositions
|
US5455046A
(en)
*
|
1993-09-09 |
1995-10-03 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US6726930B1
(en)
*
|
1993-09-09 |
2004-04-27 |
Penwest Pharmaceuticals Co. |
Sustained release heterodisperse hydrogel systems for insoluble drugs
|
US5662933A
(en)
*
|
1993-09-09 |
1997-09-02 |
Edward Mendell Co., Inc. |
Controlled release formulation (albuterol)
|
US5773025A
(en)
*
|
1993-09-09 |
1998-06-30 |
Edward Mendell Co., Inc. |
Sustained release heterodisperse hydrogel systems--amorphous drugs
|
EP1442745A1
(de)
*
|
1993-10-07 |
2004-08-04 |
Euro-Celtique |
Oral anzuwendende opioidhaltige Zusammensetzungen mit verlängerter Wirkung
|
US5500227A
(en)
*
|
1993-11-23 |
1996-03-19 |
Euro-Celtique, S.A. |
Immediate release tablet cores of insoluble drugs having sustained-release coating
|
US6210714B1
(en)
|
1993-11-23 |
2001-04-03 |
Euro-Celtique S.A. |
Immediate release tablet cores of acetaminophen having sustained-release coating
|
KR100354702B1
(ko)
*
|
1993-11-23 |
2002-12-28 |
유로-셀티크 소시에떼 아노뉨 |
약학조성물의제조방법및서방형조성물
|
US5891471A
(en)
*
|
1993-11-23 |
1999-04-06 |
Euro-Celtique, S.A. |
Pharmaceutical multiparticulates
|
US5843480A
(en)
*
|
1994-03-14 |
1998-12-01 |
Euro-Celtique, S.A. |
Controlled release diamorphine formulation
|
US5914131A
(en)
*
|
1994-07-07 |
1999-06-22 |
Alza Corporation |
Hydromorphone therapy
|
GB9422154D0
(en)
|
1994-11-03 |
1994-12-21 |
Euro Celtique Sa |
Pharmaceutical compositions and method of producing the same
|
US20020006438A1
(en)
*
|
1998-09-25 |
2002-01-17 |
Benjamin Oshlack |
Sustained release hydromorphone formulations exhibiting bimodal characteristics
|
US5871776A
(en)
*
|
1995-01-31 |
1999-02-16 |
Mehta; Atul M. |
Controlled-release nifedipine
|
DE19531684A1
(de)
*
|
1995-08-29 |
1997-03-06 |
Bayer Ag |
Verfahren zur Herstellung von Arzneimittelzubereitungen mit kontrollierter Freisetzung
|
GB9519363D0
(en)
|
1995-09-22 |
1995-11-22 |
Euro Celtique Sa |
Pharmaceutical formulation
|
AUPN603895A0
(en)
|
1995-10-19 |
1995-11-09 |
University Of Queensland, The |
Production of analgesic synergy by co-administration of sub-analgesic doses of two strong opioids
|
JP3148256B2
(ja)
|
1996-07-08 |
2001-03-19 |
エドワード メンデル カンパニー.,インコーポレーテッド |
高用量難溶性薬物用持続放出マトリックス
|
JPH1050306A
(ja)
*
|
1996-07-31 |
1998-02-20 |
Toyota Autom Loom Works Ltd |
水素吸蔵合金電極の製造方法
|
ES2212083T3
(es)
*
|
1996-10-03 |
2004-07-16 |
Hermes Biosciences, Inc. |
Microparticulas hidrofilas y procedimiento para prepararlas.
|
AU8293498A
(en)
|
1997-07-02 |
1999-01-25 |
Euro-Celtique S.A. |
Stabilized sustained release tramadol formulations
|
US6056977A
(en)
|
1997-10-15 |
2000-05-02 |
Edward Mendell Co., Inc. |
Once-a-day controlled release sulfonylurea formulation
|
US6066339A
(en)
*
|
1997-10-17 |
2000-05-23 |
Elan Corporation, Plc |
Oral morphine multiparticulate formulation
|
US20040029962A1
(en)
*
|
1997-12-12 |
2004-02-12 |
Chih-Ming Chen |
HMG-COA reductase inhibitor extended release formulation
|
US20060141036A1
(en)
*
|
1997-12-12 |
2006-06-29 |
Andrx Labs Llc |
HMG-CoA reductase inhibitor extended release formulation
|
WO1999032119A1
(en)
|
1997-12-22 |
1999-07-01 |
Euro-Celtique, S.A. |
Opioid agonist/antagonist combinations
|
UA53774C2
(uk)
*
|
1997-12-22 |
2003-02-17 |
Еро-Селтік, С.А. |
Спосіб запобігання зловживанню лікарськими формами, що містять опіоїди
|
DE19808634A1
(de)
*
|
1998-02-24 |
1999-08-26 |
Schering Ag |
Mantel für eine pharmazeutische Zusammensetzung
|
US6471975B1
(en)
|
1998-05-01 |
2002-10-29 |
3M Innovative Properties Company |
Microspheres as a delivery vehicle for bio-active agents useful in agricultural applications
|
US7354596B1
(en)
|
1998-05-01 |
2008-04-08 |
3M Innovative Properties Company |
Anti-microbial agent delivery system
|
US6312728B1
(en)
|
1998-07-07 |
2001-11-06 |
Cascade Development, Inc. |
Sustained release pharmaceutical preparation
|
US6806294B2
(en)
|
1998-10-15 |
2004-10-19 |
Euro-Celtique S.A. |
Opioid analgesic
|
US7083808B2
(en)
*
|
1998-12-17 |
2006-08-01 |
Euro-Celtique S.A. |
Controlled/modified release oral methylphenidate formulations
|
US6673367B1
(en)
|
1998-12-17 |
2004-01-06 |
Euro-Celtique, S.A. |
Controlled/modified release oral methylphenidate formulations
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
US6270807B1
(en)
|
1999-03-02 |
2001-08-07 |
L. Perrigo Company |
Taste-masked pharmaceutical composition
|
FR2794646B1
(fr)
|
1999-06-09 |
2001-09-21 |
Ethypharm Lab Prod Ethiques |
Microgranules de sulfate de morphine, procede de preparation et composition les contenant
|
IN191239B
(de)
|
1999-06-11 |
2003-10-11 |
Ranbaxy Lab Ltd |
|
US7030097B1
(en)
*
|
1999-07-14 |
2006-04-18 |
Cornell Research Foundation, Inc. |
Controlled nucleic acid delivery systems
|
CN100387228C
(zh)
*
|
1999-08-27 |
2008-05-14 |
布鲁克伍德药品公司 |
可注射的美沙酮、部分类鸦片激动剂或类鸦片拮抗剂微粒组合物及其用途
|
DE60038536T2
(de)
*
|
1999-09-30 |
2009-06-10 |
Penwest Pharmaceuticals Co. |
Matrixsystem mit verzögerter freisetzung für hochlösliche wirkstoffe
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
NZ529928A
(en)
|
1999-10-29 |
2005-10-28 |
Euro Celtique Sa |
Controlled release hydrocodone formulations
|
CA2400578C
(en)
|
2000-02-08 |
2007-01-02 |
Euro-Celtique, S.A. |
Controlled-release compositions containing opioid agonist and antagonist
|
HU229705B1
(en)
|
2000-02-08 |
2014-05-28 |
Euro Celtique Sa |
Tamper-resistant oral opioid agonist formulations
|
US6955821B2
(en)
|
2000-04-28 |
2005-10-18 |
Adams Laboratories, Inc. |
Sustained release formulations of guaifenesin and additional drug ingredients
|
US7838032B2
(en)
*
|
2000-04-28 |
2010-11-23 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin
|
US7985420B2
(en)
*
|
2000-04-28 |
2011-07-26 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
US8012504B2
(en)
*
|
2000-04-28 |
2011-09-06 |
Reckitt Benckiser Inc. |
Sustained release of guaifenesin combination drugs
|
KR101045144B1
(ko)
|
2000-10-30 |
2011-06-30 |
유로-셀티크 소시에떼 아노뉨 |
서방성 하이드로코돈 제형
|
EP1386251A4
(de)
*
|
2001-03-02 |
2005-11-23 |
Euro Celtique Sa |
Verfahren und gerät zur verdichtung von individualisierten dosierformen
|
UA81224C2
(uk)
|
2001-05-02 |
2007-12-25 |
Euro Celtic S A |
Дозована форма оксикодону та її застосування
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
ATE493130T1
(de)
|
2001-05-11 |
2011-01-15 |
Endo Pharmaceuticals Inc |
Opioid enthaltende arzneiform gegen missbrauch
|
JP2004534056A
(ja)
*
|
2001-06-08 |
2004-11-11 |
エンドー ファーマシューティカルズ, インコーポレイティド |
アクリルポリマーを使用する制御放出投薬形態、およびそれを作製するためのプロセス
|
DE60230632D1
(de)
*
|
2001-07-18 |
2009-02-12 |
Euro Celtique Sa |
Pharmazeutische kombinationen von oxycodon und naloxon
|
WO2003013433A2
(en)
*
|
2001-08-06 |
2003-02-20 |
Euro-Celtique S.A. |
Sequestered antagonist formulations
|
US20030044458A1
(en)
|
2001-08-06 |
2003-03-06 |
Curtis Wright |
Oral dosage form comprising a therapeutic agent and an adverse-effect agent
|
US20030068375A1
(en)
|
2001-08-06 |
2003-04-10 |
Curtis Wright |
Pharmaceutical formulation containing gelling agent
|
ATE431738T1
(de)
|
2001-08-06 |
2009-06-15 |
Euro Celtique Sa |
Opioid-agonist-formulierungen mit freisetzbarem und sequestriertem antagonist
|
WO2003020242A1
(en)
*
|
2001-08-29 |
2003-03-13 |
Srl Technologies, Inc. |
Sustained release preparations
|
PE20030527A1
(es)
|
2001-10-24 |
2003-07-26 |
Gruenenthal Chemie |
Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
|
US20100311701A1
(en)
*
|
2002-02-15 |
2010-12-09 |
Transform Pharmaceuticals, Inc |
Pharmaceutical Co-Crystal Compositions
|
US7927613B2
(en)
*
|
2002-02-15 |
2011-04-19 |
University Of South Florida |
Pharmaceutical co-crystal compositions
|
WO2004026235A2
(en)
*
|
2002-09-20 |
2004-04-01 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
US20090088443A1
(en)
*
|
2002-02-15 |
2009-04-02 |
Julius Remenar |
Novel crystalline forms of conazoles and methods of making and using the same
|
US7790905B2
(en)
*
|
2002-02-15 |
2010-09-07 |
Mcneil-Ppc, Inc. |
Pharmaceutical propylene glycol solvate compositions
|
AU2003213719A1
(en)
*
|
2002-03-01 |
2003-09-16 |
Regents Of The University Of Michigan |
Multiple-component solid phases containing at least one active pharmaceutical ingredient
|
EP2243471A1
(de)
*
|
2002-04-05 |
2010-10-27 |
Euro-Celtique S.A. |
Matrix für die modifizierte Freigabe von aktiven Substanzen
|
AU2003243699B2
(en)
|
2002-06-21 |
2009-01-15 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical compositions with improved dissolution
|
ES2358896T3
(es)
|
2002-08-15 |
2011-05-16 |
Euro-Celtique S.A. |
Composiciones farmacéuticas que comprenden un analgésico opioide.
|
DK1551372T3
(en)
*
|
2002-09-20 |
2018-07-23 |
Alpharma Pharmaceuticals Llc |
SEQUERATION SUBSTANCES AND RELATED COMPOSITIONS AND PROCEDURES
|
EP1545468A4
(de)
*
|
2002-09-20 |
2007-06-20 |
Alpharma Inc |
Opioid-formulierungen mit verz gerter freisetzung und anwendungsverfahren
|
TWI319713B
(en)
*
|
2002-10-25 |
2010-01-21 |
|
Sustained-release tramadol formulations with 24-hour efficacy
|
US8487002B2
(en)
*
|
2002-10-25 |
2013-07-16 |
Paladin Labs Inc. |
Controlled-release compositions
|
WO2004047752A2
(en)
*
|
2002-11-26 |
2004-06-10 |
Transform Pharmaceuticals, Inc. |
Pharmaceutical formulations of celcoxib
|
DK1575569T3
(da)
|
2002-12-13 |
2011-01-10 |
Durect Corp |
Oralt indgivelsessystem omfattende flydende bærematerialer med høj viskositet
|
EP2339328A3
(de)
|
2002-12-30 |
2011-07-13 |
Transform Pharmaceuticals, Inc. |
Pharmazeutische kokristallisierte Celecoxib-Zusammensetzungen
|
US8183290B2
(en)
*
|
2002-12-30 |
2012-05-22 |
Mcneil-Ppc, Inc. |
Pharmaceutically acceptable propylene glycol solvate of naproxen
|
US20040202717A1
(en)
|
2003-04-08 |
2004-10-14 |
Mehta Atul M. |
Abuse-resistant oral dosage forms and method of use thereof
|
TWI347201B
(en)
|
2003-04-21 |
2011-08-21 |
Euro Celtique Sa |
Pharmaceutical products,uses thereof and methods for preparing the same
|
US20060165790A1
(en)
*
|
2003-06-27 |
2006-07-27 |
Malcolm Walden |
Multiparticulates
|
TWI357815B
(en)
*
|
2003-06-27 |
2012-02-11 |
Euro Celtique Sa |
Multiparticulates
|
US20050048118A1
(en)
*
|
2003-07-25 |
2005-03-03 |
Joan Cucala Escoi |
Modified release venlafaxine hydrochloride tablets
|
EP2298303A1
(de)
|
2003-09-25 |
2011-03-23 |
Euro-Celtique S.A. |
Pharmazeutische kombinationen von hydrocodon und naltrexon
|
NZ546183A
(en)
*
|
2003-09-26 |
2011-04-29 |
Alza Corp |
Controlled release formulations exhibiting an ascending rate of release
|
MXPA06003453A
(es)
*
|
2003-09-26 |
2006-08-31 |
Johnson & Johnson |
Barra de empuje oros para el suministro controlado de agentes activos.
|
NZ546148A
(en)
|
2003-09-26 |
2009-05-31 |
Alza Corp |
Drug coating providing high drug loading and methods for providing the same
|
JP5563731B2
(ja)
*
|
2003-09-26 |
2014-07-30 |
アルザ・コーポレーシヨン |
オピオイドおよび非オピオイド鎮痛薬の制御放出製剤
|
US20060172006A1
(en)
*
|
2003-10-10 |
2006-08-03 |
Vincent Lenaerts |
Sustained-release tramadol formulations with 24-hour clinical efficacy
|
US20050084540A1
(en)
*
|
2003-10-17 |
2005-04-21 |
Indranil Nandi |
Taste masking antibiotic composition
|
CA2548917C
(en)
|
2003-12-11 |
2014-09-23 |
Sepracor Inc. |
Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
|
US20050152969A1
(en)
*
|
2004-01-08 |
2005-07-14 |
Chiprich Timothy B. |
Colored liquid-filled soft capsules and method of manufacture thereof
|
WO2006079550A2
(en)
*
|
2005-01-28 |
2006-08-03 |
Euro-Celtique S.A. |
Alcohol resistant dosage forms
|
TWI365880B
(en)
|
2004-03-30 |
2012-06-11 |
Euro Celtique Sa |
Process for preparing oxycodone hydrochloride having less than 25 ppm 14-hydroxycodeinone and oxycodone hydrochloride composition,pharmaceutical dosage form,sustained release oeal dosage form and pharmaceutically acceptable package having less than 25 pp
|
EP1604667A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung des Restless Leg Syndroms
|
EP1604666A1
(de)
|
2004-06-08 |
2005-12-14 |
Euro-Celtique S.A. |
Opioide zur Behandlung der chronischen obstruktiven Lungenkrankheit
|
ES2653568T3
(es)
|
2004-06-12 |
2018-02-07 |
Collegium Pharmaceutical, Inc. |
Formulaciones de fármacos para la prevención del abuso
|
US7776358B2
(en)
*
|
2004-07-22 |
2010-08-17 |
Synthon Ip Inc. |
Extended release venlafaxine besylate tablets
|
DE102004035938A1
(de)
*
|
2004-07-23 |
2006-02-16 |
Röhm GmbH & Co. KG |
Verfahren zur Herstellung von überzogenen Arzneiformen mit stabilem Wirkstofffreigabeprofil
|
GB2418854B
(en)
|
2004-08-31 |
2009-12-23 |
Euro Celtique Sa |
Multiparticulates
|
AU2005282784B2
(en)
*
|
2004-09-01 |
2008-06-19 |
Euro-Celtique S.A. |
Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
JP5124267B2
(ja)
*
|
2005-02-25 |
2013-01-23 |
武田薬品工業株式会社 |
顆粒の製造方法
|
EP1695700A1
(de)
*
|
2005-02-28 |
2006-08-30 |
Euro-Celtique S.A. |
Darreichungsform enthaltend Oxycodon und Naloxon
|
EP1702558A1
(de)
|
2005-02-28 |
2006-09-20 |
Euro-Celtique S.A. |
Verfahren und Vorrichtung zur Darmtätigkeitserfassung
|
FR2883179B1
(fr)
|
2005-03-18 |
2009-04-17 |
Ethypharm Sa |
Comprime enrobe
|
DE602006006663D1
(de)
*
|
2005-03-24 |
2009-06-18 |
Medtronic Inc |
Modifizierung von thermoplastischen polymeren
|
KR101655455B1
(ko)
*
|
2005-09-09 |
2016-09-07 |
안젤리니 라보팜 엘엘씨 |
일일 1회 투여를 위한 트라조돈 조성물
|
FR2894143B1
(fr)
*
|
2005-12-01 |
2008-05-02 |
Pierre Fabre Medicament Sa |
Composition a liberation prolongee de l'actif, son procede de preparation et son utilisation.
|
EP1813276A1
(de)
*
|
2006-01-27 |
2007-08-01 |
Euro-Celtique S.A. |
Manipulationssichere Dosierformen
|
WO2007092718A2
(en)
*
|
2006-02-07 |
2007-08-16 |
Fmc Corporation |
Coating process to produce controlled release coatings
|
US20070190141A1
(en)
*
|
2006-02-16 |
2007-08-16 |
Aaron Dely |
Extended release opiate composition
|
CN101400343B
(zh)
|
2006-03-16 |
2012-01-11 |
特瑞斯制药股份有限公司 |
含有药物-离子交换树脂复合物的经修饰释放的制剂
|
US20070281016A1
(en)
*
|
2006-06-06 |
2007-12-06 |
Endo Pharmaceuticals Inc., A Delaware Corporation |
Sustained release oxycodone composition with acrylic polymer and surfactant
|
US20070286900A1
(en)
|
2006-06-09 |
2007-12-13 |
Catherine Herry |
Low dose tablets of opioid analgesics and preparation process
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
CN101677963B
(zh)
|
2006-06-19 |
2012-05-30 |
奥尔制药公司 |
药物组合物
|
EP2046285B1
(de)
*
|
2006-08-04 |
2018-02-21 |
Ethypharm |
Granulat und oral zerfallende tablette mit oxycodon
|
SA07280459B1
(ar)
|
2006-08-25 |
2011-07-20 |
بيورديو فارما إل. بي. |
أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
GB0624880D0
(en)
*
|
2006-12-14 |
2007-01-24 |
Johnson Matthey Plc |
Improved method for making analgesics
|
ES2692437T3
(es)
*
|
2007-08-13 |
2018-12-03 |
Abuse Deterrent Pharmaceutical Llc |
Fármacos resistentes al abuso, método de uso y método de preparación
|
JP2008024708A
(ja)
*
|
2007-08-20 |
2008-02-07 |
Euro-Celtique Sa |
アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
|
DK2057984T3
(da)
|
2007-11-09 |
2010-05-03 |
Acino Pharma Ag |
Retardtabletter med hydromorphon
|
AU2008347158B8
(en)
|
2007-12-06 |
2013-08-22 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
US20100151014A1
(en)
*
|
2008-12-16 |
2010-06-17 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US8623418B2
(en)
*
|
2007-12-17 |
2014-01-07 |
Alpharma Pharmaceuticals Llc |
Pharmaceutical composition
|
AU2008346870A1
(en)
*
|
2007-12-17 |
2009-07-16 |
Alpharma Pharmaceuticals, Llc |
Pharmaceutical composition
|
US20100003322A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Lai Felix S |
Enteric coated hydrophobic matrix formulation
|
BRPI0910780A2
(pt)
*
|
2008-07-07 |
2016-08-09 |
Euro Celtique Sa |
uso de antagonistas de opióides para o tratamento da retenção urinária
|
DK2328539T3
(en)
|
2008-09-25 |
2018-06-18 |
Isp Investments Llc |
SOFT TABLET COATING COMPOSITION WITH HIGH DRY CONTENT
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
DK2405915T3
(en)
|
2009-03-10 |
2019-02-11 |
Euro Celtique Sa |
PHARMACEUTICAL COMPOSITIONS WITH IMMEDIATE RELEASE INCLUDING OXYCODON AND NALOXON
|
US8811578B2
(en)
*
|
2009-03-23 |
2014-08-19 |
Telemanager Technologies, Inc. |
System and method for providing local interactive voice response services
|
DE102009034308A1
(de)
*
|
2009-07-21 |
2011-02-03 |
Winkelmann, Wolfgang, Dr. |
Medizinisches Präparat zur Behandlung von entzündlichen Prozessen
|
US10668060B2
(en)
|
2009-12-10 |
2020-06-02 |
Collegium Pharmaceutical, Inc. |
Tamper-resistant pharmaceutical compositions of opioids and other drugs
|
EP2568977A1
(de)
|
2010-05-11 |
2013-03-20 |
Cima Labs Inc. |
Alkoholresistente metoprololhaltige orale retard-dosierformen
|
CN102018962B
(zh)
*
|
2010-07-16 |
2013-11-06 |
钟术光 |
在控释制剂中的聚合物增强剂
|
CN101987083B
(zh)
*
|
2010-07-16 |
2012-12-12 |
钟术光 |
一种控释制剂特别是零级释放的控释制剂制备方法
|
US8623409B1
(en)
|
2010-10-20 |
2014-01-07 |
Tris Pharma Inc. |
Clonidine formulation
|
ES2444591T3
(es)
|
2010-10-28 |
2014-02-25 |
Acino Pharma Ag |
Medicamento con el principio activo hidromorfona con estabilidad al almacenamiento mejorada
|
WO2012080833A2
(en)
|
2010-12-13 |
2012-06-21 |
Purdue Pharma L.P. |
Controlled release dosage forms
|
CN103370058A
(zh)
|
2010-12-22 |
2013-10-23 |
普渡制药公司 |
包覆的抗篡改控制释放剂型
|
CN107412173A
(zh)
|
2010-12-23 |
2017-12-01 |
普渡制药公司 |
抗篡改固体口服剂型
|
JP5146859B2
(ja)
*
|
2011-07-11 |
2013-02-20 |
ユーロ−セルティーク エス.エイ. |
アクリル系ポリマーの水性分散液で被膜した放出制御型製剤及びその方法
|
CA3120681A1
(en)
|
2012-04-17 |
2013-10-24 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
CN104507947B
(zh)
|
2012-07-16 |
2017-06-27 |
罗德科技公司 |
用于改进的阿片样物质合成的方法
|
JP6236447B2
(ja)
|
2012-07-16 |
2017-11-22 |
ローズ テクノロジーズ |
改善されたオピオイド合成方法
|
MX2015010041A
(es)
|
2013-02-05 |
2015-10-30 |
Purdue Pharma Lp |
Formulacion farmaceuticas resistentes a la alteracion.
|
CN105120659A
(zh)
|
2013-03-15 |
2015-12-02 |
度瑞公司 |
用于降低溶解可变性的具有流变改性剂的组合物
|
US10751287B2
(en)
|
2013-03-15 |
2020-08-25 |
Purdue Pharma L.P. |
Tamper resistant pharmaceutical formulations
|
KR20180037074A
(ko)
|
2013-07-23 |
2018-04-10 |
유로-셀티큐 에스.에이. |
장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
|
EP3027622B8
(de)
|
2013-08-02 |
2019-06-12 |
Johnson Matthey Public Limited Company |
Verfahren zur herstellung von oxymorphon
|
JP2017502991A
(ja)
|
2014-01-15 |
2017-01-26 |
ローズ テクノロジーズ |
改良されたオキシコドン合成のための方法
|
WO2015107472A1
(en)
|
2014-01-15 |
2015-07-23 |
Rhodes Technologies |
Process for improved oxymorphone synthesis
|
US9062063B1
(en)
|
2014-03-21 |
2015-06-23 |
Johnson Matthey Public Limited Company |
Forms of oxymorphone hydrochloride
|
US9849124B2
(en)
|
2014-10-17 |
2017-12-26 |
Purdue Pharma L.P. |
Systems and methods for treating an opioid-induced adverse pharmacodynamic response
|
CA2936741C
(en)
|
2014-10-31 |
2018-11-06 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
US9918979B2
(en)
|
2015-01-29 |
2018-03-20 |
Johnson Matthey Public Limited Company |
Process of preparing low ABUK oxymorphone hydrochloride
|
US10004749B2
(en)
|
2015-07-22 |
2018-06-26 |
John Hsu |
Composition comprising a therapeutic agent and a respiratory stimulant and methods for the use thereof
|
US11590228B1
(en)
|
2015-09-08 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine compositions
|
US20170086312A1
(en)
*
|
2015-09-17 |
2017-03-23 |
Syed Taymur Ahmad |
Process for protecting an electronic device by selective deposition of polymer coatings
|
US9943513B1
(en)
|
2015-10-07 |
2018-04-17 |
Banner Life Sciences Llc |
Opioid abuse deterrent dosage forms
|
US11278506B2
(en)
|
2015-10-09 |
2022-03-22 |
Rb Health (Us) Llc |
Pharmaceutical formulation
|
US10335405B1
(en)
|
2016-05-04 |
2019-07-02 |
Patheon Softgels, Inc. |
Non-burst releasing pharmaceutical composition
|
US9737530B1
(en)
|
2016-06-23 |
2017-08-22 |
Collegium Pharmaceutical, Inc. |
Process of making stable abuse-deterrent oral formulations
|
US20180083662A1
(en)
*
|
2016-09-16 |
2018-03-22 |
Syed Taymur Ahmad |
Process for protecting an electronic device by selective deposition of polymer coatings
|
US10335375B2
(en)
|
2017-05-30 |
2019-07-02 |
Patheon Softgels, Inc. |
Anti-overingestion abuse deterrent compositions
|
EP3459527B1
(de)
*
|
2017-09-20 |
2022-11-23 |
Tillotts Pharma Ag |
Verfahren zur herstellung einer festen dosierungsform mit antikörpern durch nassgranulation, -extrusion und -sphäronisierung
|
US11590081B1
(en)
|
2017-09-24 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine tablets
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
US11918689B1
(en)
|
2020-07-28 |
2024-03-05 |
Tris Pharma Inc |
Liquid clonidine extended release composition
|